原題
(177)Lu-PSMA-617 Consolidation Therapy After Docetaxel in Patients with Synchronous High-Volume Metastatic Hormone-Sensitive Prostate Cancer: A Randomized, Phase 2 Trial.

Journal: J Nucl Med (CiteScore 2022: 12.9)
DOI: 10.2967/jnumed.125.269913
PMID: 40404393